Allogene Therapeutics Inc...

NASDAQ: ALLO · Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT

Allogene Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.61 -1.54 -2.64 -11.13
PEG Ratio
0.04 0.13 -0.03 0.31
PS Ratio
18.86K 5.3K 5.77K 17.76
PB Ratio
0.98 0.98 1.35 2.21
P/FCF Ratio
-2.06 -2.11 -3.99 -9.82
P/OCF Ratio
-2.07 -2.12 -4.08 -10.96
OCF/S Ratio
-9.1K -2.5K -1.41K -1.62
Debt / Equity Ratio
0.21 0.19 0.15 0.08
Quick Ratio
8.54 12.38 10.85 10.26
Current Ratio
8.54 12.38 9.70 9.84
Asset Turnover
0.00 0.00 0.00 0.11
Interest Coverage
-1.51K n/a n/a n/a
Return on Equity
-0.61 -0.64 -0.51 -0.2
Return on Assets
-0.47 -0.51 -0.42 -0.18
Return on Invested Capital
-0.52 -0.53 -0.43 -0.27
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 -90.63 0.91
Net Profit Margin
-11.71K -3.44K -2.18K -1.6
Pretax Profit Margin
-11.69K -3.44K -2.18K -1.6
Operating Profit Margin
-12.42K -3.45K -2.15K -1.58
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-11.06K -3.3K -2.06K -1.49